LUCD luciddx.com: Prakiraan wutah bathi resik saben saham kanggo taun ngarep
The innovative EsoGuard test provides high diagnostic reliability, replacing invasive endoscopy. Price stability confirms the earnings per share (EPS) forecast for the coming year, where the latest value is recorded as 31.50. The financial stability of Lucid Diagnostics Inc. (LUCD) relies on inelastic demand in gastroenterology and the implementation of AI modules to automate laboratory reports, which optimizes the company's operating expenses.
LUCD (luciddx.com): rincian analitis lan laporan miturut indikator
- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
- rincian nilai buku perusahaan:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Lucid Diagnostics Inc.|LUCD - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Lucid Diagnostics|LUCD - Utang agregat perusahaan|Utang marang nilai buku Lucid Diagnostics|LUCD - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Lucid Diagnostics|Rasio cepet luciddx.com
- statistik bathi lan rasio pasar:
LUCD - Asil keuangan resik|Proyeksi bathi mangsa ngarep Lucid Diagnostics Inc.|LUCD - Pangali P/E|Pangali Forward P/E Lucid Diagnostics Inc.|LUCD - Rasio rega marang wutah bathi resik|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Lucid Diagnostics|LUCD - Bathi operasional sadurunge amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Lucid Diagnostics|LUCD - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan luciddx.com|LUCD - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Lucid Diagnostics Inc.
Analisis umum perusahaan:Lucid Diagnostics Inc
The integration of the EsoGuard system into oncology diagnostic standards makes the profit growth forecast for the coming year an indicator of the monetization of the technological advantage of Lucid Diagnostics Inc. (LUCD). This metric calculates the expected change in earnings per share, assessing the business's future ability to generate free cash flow. By analyzing the trend of the forward net income figure, an investor determines the scaling pace of the ecosystem. Positive dynamics confirm the capital's resilience to costs and the reliability of debt service.
Analisis pesaing Lucid Diagnostics Inc.
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|Quest Corp (DGX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Illumina, Inc. (ILMN)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep EXAS (exactsciences.com)|Revvity - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Bio-Rad Laboratories, Inc. BIO|Anbio Tech - Prakiraan wutah bathi kanggo taun ngarep|Nordion (SHC) - Prakiraan wutah bathi saben saham kanggo taun ngarep|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPK - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|CDNA (CareDx, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep MRVI (Maravai LifeSciences Holdings)|Prakiraan wutah bathi saben saham kanggo taun ngarep FLGT (Fulgent Corp)|LAB (Standard BioTools Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences, Inc.)|OSUR: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Exagen Diagnostics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep MDxHealth S.A. MDXH|PRE: Prakiraan wutah bathi kanggo taun ngarep|Insight Molecular Diagnostics Inc (IMDX) - Prakiraan wutah bathi kanggo taun ngarep|TRIB (Trinity Biotech PLC) - Prakiraan wutah bathi kanggo taun ngarep|PRPH - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Ainos (AIMD)|Co-Diagnostics Inc - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Heart Test Laboratories Inc. HSCS|Biomerica Inc (BMRA) - Prakiraan wutah bathi resik saben saham ing taun ngarep|CDIO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep onconetix.gcs-web.com ONCO|VRAX (Virax Biolabs) - Prakiraan wutah bathi saben saham kanggo taun ngarep|BJDX: Proyeksi tambahing bathi saben saham ing taun ngarep|AWH (Vermillion) - Prakiraan wutah bathi kanggo taun ngarep|Accelerate Diagnostics Inc (AXDX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CNTG|Prakiraan wutah bathi saben saham kanggo taun ngarep enzo.com ENZ|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fresh2 Group FRES|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Genetic Technologies Ltd (GENE)|ME: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep PMD (Psychemedics Inc)
